 Methicillin-Resistant Staphylococcus aureus
"Methicillin-Resistant Staphylococcus aureus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS.
| Descriptor ID |
D055624
|
| MeSH Number(s) |
B03.300.390.400.800.750.100.500 B03.353.500.750.750.100.500 B03.510.100.750.750.100.500 B03.510.400.790.750.100.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Methicillin-Resistant Staphylococcus aureus".
Below are MeSH descriptors whose meaning is more specific than "Methicillin-Resistant Staphylococcus aureus".
This graph shows the total number of publications written about "Methicillin-Resistant Staphylococcus aureus" by people in this website by year, and whether "Methicillin-Resistant Staphylococcus aureus" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 2 | 1 | 3 | | 2009 | 3 | 0 | 3 | | 2010 | 5 | 3 | 8 | | 2011 | 9 | 1 | 10 | | 2012 | 14 | 3 | 17 | | 2013 | 8 | 1 | 9 | | 2014 | 2 | 5 | 7 | | 2015 | 7 | 3 | 10 | | 2016 | 6 | 2 | 8 | | 2017 | 5 | 5 | 10 | | 2018 | 4 | 3 | 7 | | 2019 | 7 | 2 | 9 | | 2020 | 5 | 2 | 7 | | 2021 | 5 | 2 | 7 | | 2022 | 11 | 0 | 11 | | 2023 | 9 | 1 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Methicillin-Resistant Staphylococcus aureus" by people in Profiles.
-
Zehr EP, Erzen CL, Oshima K, Langouet-Astrie CJ, LaRiviere WB, Shi D, Zhang F, McCollister BD, Windham SL, Rizzo AN, Bastarache JA, Horswill AR, Schmidt EP, Kwiecinski JM, Colbert JF. Bacterial pneumonia-induced shedding of epithelial heparan sulfate inhibits the bactericidal activity of cathelicidin in a murine model. Am J Physiol Lung Cell Mol Physiol. 2024 02 01; 326(2):L206-L212.
-
Yellepeddi VK, Lindley B, Radetich E, Kumar S, Bhakta Z, Leclair L, Parrot M, Young DC. Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis. Antimicrob Agents Chemother. 2024 Jan 10; 68(1):e0099223.
-
Lindley B, Bhakta Z, Leclair L, Young DC. The pharmacokinetics and pharmacodynamics of continuous infusion vancomycin in adult people with cystic fibrosis. Pediatr Pulmonol. 2024 Jan; 59(1):89-94.
-
Holland TL, Cosgrove SE, Doernberg SB, Jenkins TC, Turner NA, Boucher HW, Pavlov O, Titov I, Kosulnykov S, Atanasov B, Poromanski I, Makhviladze M, Anderzhanova A, Stryjewski ME, Assadi Gehr M, Engelhardt M, Hamed K, Ionescu D, Jones M, Saulay M, Smart J, Seifert H, Fowler VG. Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia. N Engl J Med. 2023 Oct 12; 389(15):1390-1401.
-
Schutz J, Lalka A, Williams MA, Sibbel SE, Sinclair MK. Establishing the Role of Inflammatory Markers in the Diagnosis and Treatment of Acute Hand Infections in the Pediatric Population. J Pediatr Orthop. 2023 Nov-Dec 01; 43(10):649-653.
-
Haynes AS, Maples H, Parker S. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):308-318.
-
Frazier JD, Stoudenmire LL, Wagner JL, Thomas GM, Steele GM, Henao-Mart?nez AF, Franco-Paredes C, Chastain DB. Dalbavancin vs standard of care for Staphylococcus aureus bacteraemia in patients unable to receive outpatient parenteral antimicrobial therapy. Int J Antimicrob Agents. 2023 Jul; 62(1):106842.
-
Weig AW, O'Conner PM, Kwiecinski JM, Marciano OM, Nunag A, Gutierrez AT, Melander RJ, Horswill AR, Melander C. A structure activity relationship study of 3,4'-dimethoxyflavone for ArlRS inhibition in Staphylococcus aureus. Org Biomol Chem. 2023 04 26; 21(16):3373-3380.
-
Purtell SR, Thornhill D, Loi M, Lockwood J, Kim JS, MacBrayne CE, DeVine MN, Sanders J, Searns J. Risk Factors for Venous Thromboembolic Events in Children With Acute Musculoskeletal Infections. J Pediatr Orthop. 2023 Jul 01; 43(6):400-406.
-
Sul C, Lewis C, Dee N, Burns N, Oshima K, Schmidt E, Vohwinkel C, Nozik E. Release of extracellular superoxide dismutase into alveolar fluid protects against acute lung injury and inflammation in Staphylococcus aureus pneumonia. Am J Physiol Lung Cell Mol Physiol. 2023 04 01; 324(4):L445-L455.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|